Sutro Biopharma, Inc.

Contributing Author

Recent Articles by Sutro Biopharma, Inc.

Dec-17	Sutro Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement STRO GlobeNewswire
Dec-16	Sutro Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) STRO GlobeNewswire
Dec-03	Sutro Biopharma Announces First Cohort of Patients Dosed in Phase 1 Trial of STRO-004, a Next-Generation Tissue Factor ADC, in TF-Expressing Solid Tumors STRO GlobeNewswire
Dec-01	Sutro Biopharma Announces 1-for-10 Reverse Stock Split STRO GlobeNewswire
Nov-12	Sutro Biopharma Highlights Next-Generation ADC Innovation at Virtual R&D Day STRO GlobeNewswire
Nov-06	Sutro Biopharma Reports Third Quarter 2025 Financial Results and Business Highlights STRO GlobeNewswire
Nov-05	Sutro Biopharma to Host Virtual Research & Development Day on November 12, 2025 STRO GlobeNewswire
Nov-03	Sutro Biopharma Announces Participation at the 16th Annual World ADC Conference STRO GlobeNewswire
Sep-29	Sutro Biopharma Announces Operational Restructuring Intended to Extend Cash Runway through Key Milestones STRO GlobeNewswire
Aug-07	Sutro Biopharma Reports Second Quarter 2025 Financial Results and Business Highlights STRO GlobeNewswire
Jul-22	Sutro Biopharma Announces Research Collaboration with the FDA to Advance Regulatory Standards for Antibody Drug Conjugates STRO GlobeNewswire
Jun-02	Sutro Biopharma Appoints Greg Chow as Chief Financial Officer STRO GlobeNewswire
May-08	Sutro Biopharma Reports First Quarter 2025 Financial Results and Business Highlights STRO GlobeNewswire
May-01	Sutro Biopharma to Participate in Upcoming Investor Conferences STRO GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 Finviz.com. All Rights Reserved.